Vaccine, influenza


Generic Medicine Info
Contraindications
Hypersensitivity to any influenza vaccine, egg or chicken proteins. Severely immunosuppressed patients (e.g. HIV patients). Concomitant salicylate therapy (nasal).
Special Precautions
Patient with asthma, acute illness, recurrent or active wheezing (children <5 years), CV disorders, personal or family history of febrile convulsions, history of Guillain-Barre syndrome; nasal congestion (nasal). Postpone vaccination in patients with active infection or acute febrile illness. Children. Pregnancy and lactation. Monitoring Parameters Monitor for signs of anaphylaxis.
Adverse Reactions
Significant: Syncope, hyperventilation, stress-related reactions, paraesthesia, transient visual disturbance, tonic-clonic limb movements. Cardiac disorders: Chest tightness. Gastrointestinal disorders: Sore throat, abdominal pain, gastroenteritis, nausea, vomiting. General disorders and administration site conditions: Irritability, lethargy, fatigue, weakness, malaise, diaphoresis; injection site reactions (e.g. erythema, bruising, swelling). Infections and infestations: Infection, varicella. Metabolism and nutrition disorders: Decreased appetite. Musculoskeletal and connective tissue disorders: Myalgia, chills, arthralgia, back pain. Nervous system disorders: Headache, migraine. Psychiatric disorders: Drowsiness. Respiratory, thoracic and mediastinal disorders: Cough, nasal congestion, rhinorrhoea. Skin and subcutaneous tissue disorders: Ecchymosis. Vascular disorders: Hypertension.
Potentially Fatal: Severe hypersensitivity (e.g. anaphylaxis).
ROUTE(S) : Intradermal: B
ROUTE(S) : Nasal / Parenteral: C
Drug Interactions
Decreased immunological response with immunosuppressants.
CIMS Class
Vaccines, Antisera & Immunologicals
Disclaimer: This information is independently developed by CIMS based on vaccine, influenza from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in